Phoenix, AZ – According to filings with the U.S. Securities and Exchange Commission, Visiongate is raising $10,000,000.00 in a new round of investment. Sources indicate as part of senior management President, Scarlett Spring played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About VisionGate

VisionGate, Inc., founded by our CEO Dr. Alan Nelson, is a clinical stage oncology pharmaceutical and diagnostics company with a focus on saving lives by developing new products for the early detection, prevention and treatment of cancer, including lung cancer and lung dysplasia.

To learn more about VisionGate, visit http://www.visiongate3d.com/

Contact:
Scarlett Spring, President
602-368-2118
spring@visiongate3d.com
https://www.linkedin.com/in/scarlett-spring-871a077/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved